Investors

OPTIMIZED BY EVOLUTION

Wugen is developing off-the-shelf cellular therapies for cancer

Our cell therapy products originate from healthy donors and are optimized to enhance their anti-tumor function.

  • Abingworth Bioventures
  • Aisling Capital
  • Alexandria Venture Investments
  • BioGenerator
  • Alpha Wave
  • Fidelity Management & Research Company, LLC
  • Intermediate Capital Group (ICG)
  • Lightchain Capital
  • LYZZ Capital
  • RiverVest Ventures
  • Sands Capital
  • Tybourne Capital Management
  • Velosity Capital Management
ST. LOUIS

4260 Forest Park Ave
Suite 100
St. Louis, MO 63108
(636) 385-5306

SAN DIEGO

9880 Campus Point Dr
Suite 430
San Diego, CA 92121

SOCIAL

Copyright © 2023 Wugen. All Rights Reserved.

Privacy Notice

a COGNEO design